278 related articles for article (PubMed ID: 8662966)
21. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
Jong MC; Rensen PC; Dahlmans VE; van der Boom H; van Berkel TJ; Havekes LM
J Lipid Res; 2001 Oct; 42(10):1578-85. PubMed ID: 11590213
[TBL] [Abstract][Full Text] [Related]
22. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease.
Maranhão RC; Feres MC; Martins MT; Mesquita CH; Toffoletto O; Vinagre CG; Gianinni SD; Pileggi F
Atherosclerosis; 1996 Sep; 126(1):15-25. PubMed ID: 8879430
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis.
Rensen PC; Jong MC; van Vark LC; van der Boom H; Hendriks WL; van Berkel TJ; Biessen EA; Havekes LM
J Biol Chem; 2000 Mar; 275(12):8564-71. PubMed ID: 10722695
[TBL] [Abstract][Full Text] [Related]
24. Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo.
Evans AJ; Wolfe BM; Strong WL; Huff MW
Metabolism; 1993 Jan; 42(1):105-15. PubMed ID: 8446037
[TBL] [Abstract][Full Text] [Related]
25. Triolein-phosphatidylcholine-cholesterol emulsions as substrates for lipoprotein and hepatic lipases.
Clark SB; Laboda HL
Lipids; 1991 Jan; 26(1):68-73. PubMed ID: 2051886
[TBL] [Abstract][Full Text] [Related]
26. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms.
Evans AJ; Sawyez CG; Wolfe BM; Connelly PW; Maguire GF; Huff MW
J Lipid Res; 1993 May; 34(5):703-17. PubMed ID: 8509711
[TBL] [Abstract][Full Text] [Related]
27. 'In vitro' cholesteryl ester bidirectional flow between high-density lipoproteins and triglyceride-rich emulsions: effects of particle concentration and composition, cholesteryl ester transfer activity and oleic acid.
Oliveira HC; Quintão EC
J Biochem Biophys Methods; 1996 Apr; 32(1):45-57. PubMed ID: 8773547
[TBL] [Abstract][Full Text] [Related]
28. Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.
Larsson M; Vorrsjö E; Talmud P; Lookene A; Olivecrona G
J Biol Chem; 2013 Nov; 288(47):33997-34008. PubMed ID: 24121499
[TBL] [Abstract][Full Text] [Related]
29. Effects of sphingomyelin and phosphatidylcholine acyl chains on the clearance of triacylglycerol-rich lipoproteins from plasma. Studies with lipid emulsions in rats.
Redgrave TG; Rakic V; Mortimer BC; Mamo JC
Biochim Biophys Acta; 1992 Jun; 1126(1):65-72. PubMed ID: 1606176
[TBL] [Abstract][Full Text] [Related]
30. Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver.
Skottova N; Savonen R; Lookene A; Hultin M; Olivecrona G
J Lipid Res; 1995 Jun; 36(6):1334-44. PubMed ID: 7666010
[TBL] [Abstract][Full Text] [Related]
31. Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue.
den Boer MA; Berbée JF; Reiss P; van der Valk M; Voshol PJ; Kuipers F; Havekes LM; Rensen PC; Romijn JA
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):124-9. PubMed ID: 16269669
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous measurements of chylomicron lipolysis and remnant removal using a doubly labeled artificial lipid emulsion: studies in normolipidemic and hyperlipidemic subjects.
Nakandakare ER; Lottenberg SA; Oliveira HC; Bertolami MC; Vasconcelos KS; Sperotto G; Quintão EC
J Lipid Res; 1994 Jan; 35(1):143-52. PubMed ID: 8138715
[TBL] [Abstract][Full Text] [Related]
33. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. Evidence for slow metabolism via an alternative apoE-dependent pathway.
Mortimer BC; Beveridge DJ; Martins IJ; Redgrave TG
J Biol Chem; 1995 Dec; 270(48):28767-76. PubMed ID: 7499399
[TBL] [Abstract][Full Text] [Related]
34. Chylomicron metabolism is markedly altered in systemic lupus erythematosus.
Borba EF; Bonfá E; Vinagre CG; Ramires JA; Maranhão RC
Arthritis Rheum; 2000 May; 43(5):1033-40. PubMed ID: 10817556
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of chylomicron phosphatidylinositol in the rat: fate in vivo and hydrolysis with lipoprotein lipase and hepatic lipase in vitro.
Nilsson A; Chen Q; Dahlman E
J Lipid Res; 1994 Dec; 35(12):2151-60. PubMed ID: 7897313
[TBL] [Abstract][Full Text] [Related]
37. Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrin-sensitive and apolipoprotein E-independent pathway.
Crawford SE; Borensztajn J
J Lipid Res; 1999 May; 40(5):797-805. PubMed ID: 10224148
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro.
Medh JD; Bowen SL; Fry GL; Ruben S; Andracki M; Inoue I; Lalouel JM; Strickland DK; Chappell DA
J Biol Chem; 1996 Jul; 271(29):17073-80. PubMed ID: 8663292
[TBL] [Abstract][Full Text] [Related]
39. Evidence of dual pathways for lipid uptake during chylomicron remnant-like particle processing by human macrophages.
Napolitano M; Bravo E
J Vasc Res; 2006; 43(4):355-66. PubMed ID: 16791007
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.
Merkel M; Loeffler B; Kluger M; Fabig N; Geppert G; Pennacchio LA; Laatsch A; Heeren J
J Biol Chem; 2005 Jun; 280(22):21553-60. PubMed ID: 15774484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
